Projects and registries
Ongoing projects and registries
TITLE
Long-term outcomes of patients with coronary spasm associated with eosinophilia: the SPASMEO multicentric retrospective study
scientific director
Dr Matthieu Groh, Internal Medicine Department, CEREO (Reference coordinating center of hypereosinophilic syndrome in France) – Foch Hospital
AIM
– To set up the first international multicentric cohort of patients with eosinophilia-associated coronary vasospasms to provide an in-depth report of the clinical picture and MRI findings of EGPA
– To estimate survival rates, shed light on predictors of relapse
– Eventually, to provide a practical data-driven therapeutic algorithm for EGPA.
TITLE
Eosinophilia-related temporal arteritis
PROMOTER/PI
Prof Benjamin Terrier, Cochin Hospital, Paris, France
AIM
This study will allow to specify the existence or not of an eosinophilic temporal arteritis, whose characteristics and prognosis could differ from giant cell arteritis. Also, the therapeutic management could be specified.
TITLE
Impact of mepolizumab on patient-reported outcomes in eosinophilic granulomatosis with polyangiitis by using ANCA-associated vasculitis patient-reported outcomes (AAV-PRO) questionnaire: the faster the better?
PROMOTER/PI
Sara Monti and Paolo Delvino, University of Pavia, Italy
AIM
To assess the effect of mepolizumab on patient-reported outcomes in patients with refractory ENT manifestations and/or asthma secondary to EGPA by using the AAV PRO questionnaire.
TITLE
Effectiveness and Safety of Benralizumab in patients with EGPA: a retrospective study
PROMOTER/PI
Giacomo Emmi and Augusto Vaglio, University of Firenze, Italy
AIM
To investigate retrospectively the efficacy and safety of benralizumab in EGPA patients.
TITLE
EGPA onset during biologic treatment for severe asthma
PROMOTER/PI
Marco Caminati, University of Verona, Italy
AIM
To assess the prevalence of EGPA onset during the course of biologic treatment with anti-IL-5, anti-IgE or anti IL-4/IL-13 treatments, prescribed for severe asthma.
TITLE
Efficacy and safety of Rituximab in EPGA patients with renal involvement
PROMOTER/PI
Dario Roccatello, University of Torino, Italy
AIM
TITLE
Therapeutic approaches in myeloperoxidase (MPO)-associated interstitial lung disease (ILD): a multicentre study
PROMOTER/PI
Giacomo Emmi, University of Firenze, Italy